drug
remifentanil hydrochloride
Marketedupdated 3mo agoby Mylan Institutional Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(17)
approval · 17
Jul 12, 1996
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jun 23, 1999
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Oct 15, 1999
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Nov 23, 1999
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Sep 19, 2000
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Nov 19, 2001
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Oct 3, 2002
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 20, 2002
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Mar 8, 2004
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jun 11, 2013
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jan 12, 2016
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 16, 2016
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Jun 21, 2018
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Oct 7, 2019
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 15, 2023
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 22, 2025
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Dec 22, 2025
approval
ULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approval
remifentanil hydrochloride
→
Trials studying remifentanil hydrochloride
- phase3BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
- phase2A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
- phase2A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)
- phase2Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants
- phase2Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
- phase3Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
- phase1A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults
- phase2Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that